Gadolinium-loaded chitosan nanoparticles as magnetic resonance imaging contrast agents for the diagnosis of tumor

Journal of Biomedical Nanotechnology

Volumn 9, Issue 5, 2013, Pages 863-869

  Zhang, Li ^a   Liu, Yongjun ^a   Yu, Dexin ^b   Zhang, Na ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Chitosan; Contrast Agents; Gadolinium; Magnetic Resonance Imaging; Nanoparticles

Indexed keywords

CONTRAST AGENT; DIETHYLENETRIAMINE PENTA-ACETIC ACIDS; INDUCTIVELY COUPLED PLASMA-OPTICAL EMISSION SPECTROSCOPY; MAGNETIC RESONANCE IMAGES; MAGNETIC RESONANCE IMAGING (MRI); MAGNETIC RESONANCE IMAGING CONTRAST AGENTS; PHYSICOCHEMICAL PROPERTY; TRANSMISSION ELECTRON MICROSCOPE;

CHITOSAN; CYTOTOXICITY; EMISSION SPECTROSCOPY; GADOLINIUM; GELATION; INDUCTIVELY COUPLED PLASMA; MAGNETIC RESONANCE IMAGING; MAMMALS; NANOPARTICLES; TRANSMISSION ELECTRON MICROSCOPY; TUMORS; ZETA POTENTIAL;

DIAGNOSIS;

1 (3 DIMETHYLAMINOPROPYL) 3 ETHYLCARBODIIMIDE; CHITOSAN; GADOLINIUM; GADOLINIUM PENTETATE; GADOLINIUM PENTETATE MEGLUMINE; N HYDROXYSUCCINIMIDE; NANOPARTICLE; TRIPOLYPHOSPHATE;

ANIMAL EXPERIMENT; ARTICLE; GELATION; INDUCTIVELY COUPLED PLASMA OPTICAL EMISSION SPECTROSCOPY; IONIC GELATION; LIGHT SCATTERING; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; SPECTROSCOPY; TRANSMISSION ELECTRON MICROSCOPY; TUMOR DIAGNOSIS;

ANIMALS; CELL LINE, TUMOR; CELL SURVIVAL; CHITOSAN; CONTRAST MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; GADOLINIUM; MAGNETIC RESONANCE IMAGING; MELANOMA, EXPERIMENTAL; MICE; NANOPARTICLES; NEOPLASMS; SKIN NEOPLASMS;

EID: 84877737249     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2013.1584     Document Type: Article

References (25)

1. P. Agrawal, G. J. Strijkers, and K. Nicolay, Chitosan-based systems for molecular imaging. Adv. Drug Deliver. Rev. 62, 42 (2010).
2. O. Veiseh, J. W. Gunn, and M. Zhang, Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Adv. Drug. Deliver. Rev. 62, 284 (2010).
3. J. Park, P. A. N. Reddy, H. K. Kim, I. S. Kim, G. C. Kim, Y. Chang, and T. J. Kim, Gold nanoparticles functionalised by Gd-complex of DTPA-bis (amide) conjugate of glutathione as an MRI contrast agent. Bioorg. Med. Chem. Lett. 18, 6135 (2008).
4. C. Thomas, H. Wojtczyk, H. Rempp, S. Clasen, M. Horger, C. von La?berg, J. Fritz, C. D. Claussen, and P. L. Pereira, Carbon fibre and nitinol needles for MRI-guided interventions: First in vitro and in vivo application. Eur. J. Radiol. 79, 353 (2010).
5. Y. Liu, Z. Chen, C. Liu, D. Yu, Z. Lu, and N. Zhang, Gadoliniumloaded polymeric nanoparticles modified with anti-VEGF as multifunctional MRI contrast agents for the diagnosis of liver cancer. Biomaterials 32, 5167 (2011).
6. P. Sharma, S. C. Brown, G. Walter, S. Santra, Edwardscott, H. Ichikawa, Y. Fukumorl, and B. M. Moudgil, Gd nanoparticulates: From magnetic resonance imaging to neutron capture therapy. Adv. Powder. Technol. 18, 663 (2007).
7. G. P. Yan, L. Robinson, and P. Hogg, Magnetic resonance imaging contrast agents: Overview and perspectives. Radiography 13, e5 (2007).
8. Y. S. Lin, Y. Hung, J. K. Su, R. Lee, C. Chang, M. L. Lin, and C. Y. Mou, Gadolinium(III)-incorporated nanosized mesoporous silica as potential magnetic resonance imaging contrast agents. J. Phys. Chem. B 108, 15608 (2004).
9. S. Langereis, Q. G. de Lussanet, M. H. P. van Genderen, E. Meijer, R. G. H. Beets-Tan, A. W. Griffioen, J. van Engelshoven, and W. H. Backes, Evaluation of Gd(III) DTPA-terminated poly(propylene imine) dendrimers as contrast agents for MR imaging. NMR Biomed. 19, 133 (2006).
10. J. Rudovský, M. Botta, P. Hermann, K. I. Hardcastle, I. Lukeš, and S. Aime, PAMAM dendrimeric conjugates with a Gd-DOTA phosphinate derivative and their adducts with polyaminoacids: The interplay of global motion, internal rotation, and fast water exchange. Bioconjugate. Chem. 17, 975 (2006).
11. K. Luo, G. Liu, X. Zhang, W. She, B. He, Y. Nie, L. Li, Y. Wu, Z. Zhang, and Q. Gong, Functional L-lysine dendritic macromolecules as liver-imaging probes. Macromol. Biosci. 9, 1227 (2009).
12. G. A. F. van Tilborg, W. J. M. Mulder, P. T. K. Chin, G. Storm, C. P. Reutelingsperger, K. Nicolay, and G. J. Strijkers, Annexin A5-conjugated quantum dots with a paramagnetic lipidic coating for the multimodal detection of apoptotic cells. Bioconjugate Chem. 17, 865 (2006).
13. W. J. M. Mulder, R. Koole, R. J. Brandwijk, G. Storm, P. T. K. Chin, G. J. Strijkers, C. de Mello Donegá, K. Nicolay, and A. W. Griffioen, Quantum dots with a paramagnetic coating as a bimodal molecular imaging probe. Nano Lett. 6, 1 (2006).
14. S. Flacke, S. Fischer, M. J. Scott, R. J. Fuhrhop, J. S. Allen, M. McLean, P. Winter, G. A. Sicard, P. J. Gaffney, and S. A. Wickline, Novel MRI contrast agent for molecular imaging of fibrin. Circulation 104, 1280 (2001).
15. D. Zhang, X. Y. Feng, T. D. Henning, L. Wen, W. Y. Lu, H. Pan, X. Wu, and L. G. Zou, MR imaging of tumor angiogenesis using sterically stabilized Gd-DTPA liposomes targeted to CD105. Eur. J. Radiol. 70, 180 (2009).
16. N. Ding, Y. Lu, R. J. Lee, C. Yang, L. Huang, J. Liu, and G. Xiang, Folate receptor-targeted fluorescent paramagnetic bimodal liposomes for tumor imaging. Int. J. Nanomed. 6, 2513 (2011).
17. K. Shiraishi, K. Kawano, Y. Maitani, and M. Yokoyama, Polyion complex micelle MRI contrast agents from poly(ethylene glycol)-bpoly (l-lysine) block copolymers having Gd-DOTA; Preparations and their control of T1-relaxivities and blood circulation characteristics. J. Control Release 148, 160 (2010).
18. J. H. Park, G. Saravanakumar, K. Kim, and I. C. Kwon, Targeted delivery of low molecular drugs using chitosan and its derivatives. Adv. Drug Deliver. Rev. 62, 28 (2010).
19. V. Darras, M. Nelea, F. M. Winnik, and M. D. Buschmann, Chitosan modified with gadolinium diethylenetriaminepentaacetic acid for magnetic resonance imaging of DNA/chitosan nanoparticles. Carbohyd. Polym. 80, 1137 (2010).
20. F. Shikata, H. Tokumitsu, H. Ichikawa, and Y. Fukumori, In vitro cellular accumulation of gadolinium incorporated into chitosan nanoparticles designed for neutron-capture therapy of cancer. Eur. J. Pharm. Biopharm. 53, 57 (2002).
21. W. B. Y. Zhang, Multifunctional quantum-dot-based magnetic chitosan nanobeads. Adv. Mater. 17, 5 (2005).
22. Y. Liu and N. Zhang, Gadolinium loaded nanoparticles in theranostic magnetic resonance imaging. Biomaterials 33, 5363 (2012).
23. A. Trapani, J. Sitterberg, U. Bakowsky, and T. Kissel, The potential of glycol chitosan nanoparticles as carrier for low water soluble drugs. Int. J. Pharm. 375, 97 (2009).
24. S. Al-Qadi, A. Grenha, D. Carrión-Recio, B. Seijo, and C. Remúņin- López, Microencapsulated chitosan nanoparticles for pulmonary protein delivery: In vivo evaluation of insulin-loaded formulations. J. Control Release 157, 383 (2012).
25. Z. Chen, D. Yu, C. Liu, X. Yang, N. Zhang, C. Ma, J. Song, and Z. Lu, Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent. J. Drug Target 19, 657 (2011).